Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting publishing date : 2020 - 12 - 07 save search
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at AES2020, the Virtual Annual Meeting of the American Epilepsy Society
Published: 2020-12-07 (Crawled : 21:04) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K
|
Health Technology
|
| O: 0.36%
H: 6.44%
C: 3.54%
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual Meeting
Published: 2020-12-07 (Crawled : 17:01) - globenewswire.com
AUTL | $4.8 -0.83% -0.83% 1.2M
|
Health Technology
|
| O: 2.38%
H: 11.26%
C: 11.16%
TG Therapeutics Announces Pivotal Data from the UNITY-CLL and UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting
Published: 2020-12-07 (Crawled : 16:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.77%
H: 2.82%
C: -1.69%
trial
Nurix Therapeutics Presents Preclinical Data at 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 15:04) - globenewswire.com
NRIX 2 d | $14.43 2.49% 2.43% 970K
|
Health Technology
|
| O: -0.23%
H: 10.64%
C: 1.68%
preclinical pre-clinical
Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma
Published: 2020-12-07 (Crawled : 15:02) - globenewswire.com
AFMD | $5.1 -2.49% -2.55% 90K
|
Health Technology
|
| O: 5.69%
H: 18.94%
C: 13.97%
positive
TG Therapeutics Announces Triple Combination Data Presentations at the at the 62nd American Society of Hematology Annual Meeting
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.77%
H: 2.82%
C: -1.69%
Allogene Therapeutics Presents Preclinical Findings Supporting ALLO-605, the First Anti-BCMA TurboCAR™ T Cell Therapy, at the 62nd Meeting of the American Society of Hematology
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: -0.09%
H: 0.09%
C: -13.56%
therapy t-cell preclinical pre-clinical
Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at Virtual 62nd American Society of Hematology (ASH) Annual Meeting
Published: 2020-12-07 (Crawled : 15:01) - globenewswire.com
KYMR | $35.12 4.03% 3.98% 620K
|
Health Technology
|
| O: 1.31%
H: 1.98%
C: -8.25%
preclinical pre-clinical
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its ALK2 Inhibitor Program, Including KER-047 Phase 1 Data, and KER-050 Preclinical Data, at the Virtual 62nd American Society of Hematology Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 13:05) - globenewswire.com
KROS | $58.95 -0.54% -0.32% 300K
|
Health Technology
|
| O: -0.36%
H: 2.91%
C: -2.8%
results trial phase 3 phase 1 phase 2 preclinical pre-clinical
Oncternal Therapeutics Announces Presentation of Interim Phase 1/2 Data Update for Cirmtuzumab in Combination with Ibrutinib at ASH 2020 Virtual Annual Meeting
Published: 2020-12-07 (Crawled : 13:02) - globenewswire.com
ONCT | News | $8.6 -3.91% -1.82% 2.8K
|
Health Technology
|
| O: 48.5%
H: 23.29%
C: 0.76%
phase 3 phase 1 phase 2
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 13:01) - globenewswire.com
EQ | $1.73 -3.35% -1.13% 74K
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -3.67%
t-cell
MacroGenics Presents Tebotelimab Data in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma at the 2020 ASH Annual Meeting
Published: 2020-12-07 (Crawled : 13:00) - globenewswire.com
MGNX | $16.07 -0.19% -0.12% 660K
|
Health Technology
|
| O: 2.88%
H: 2.55%
C: -6.24%
t-cell
Celyad Oncology Provides Updates on Allogeneic and Autologous CAR T Programs at 62nd ASH Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 06:01) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -8.99%
H: 1.33%
C: -1.2%
car-t
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.